Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02923570 · ClinicalTrials.gov registry record · Phase 2

Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer

A Phase 2 study of Head and Neck Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 2
Development phase
108
Enrollment target
9
Study locations

NCT02923570 is a Phase 2 study of Head and Neck Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 108 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (58% lower). The trial reports 9 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02923570, a Phase 2 study of Head and Neck Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
108 participants
Enrollment target
9
Study locations

Study Summary

Compared to IMRT, PBRT is thought to give less radiation exposure to the surrounding healthy tissues. It is possible that side effect rates with PBRT will be lower or the same compared to IMRT, but this has not been well studied to date. Although both of these radiation therapies have been used in the past to treat head and neck cancer, this research study will compare the effects of these two different radiation treatment modalities with each other to see whether PBRT is better, the same or worse than IMRT.

Conditions Studied

Head and Neck Cancer

Interventions

  • RADIATION Photon intensity modulated radiation therapy (IMRT)
  • RADIATION Proton beam radiotherapy (PBRT)

Study Locations (9)

New York

  • Memorial Sloan Kettering Commack - Commack
  • Memorial Sloan Kettering Westchester - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Nassau - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge - Basking Ridge
  • Memorial Sloan Kettering Monmouth - Middletown
  • Memorial Sloan Kettering Bergen - Montvale

Florida

  • Baptist Alliance MCI - Miami

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2016-10-03
Est. Completion 2026-10
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02923570

The ClinicalTrials.gov registry entry for NCT02923570 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (58% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Photon intensity modulated radiation therapy (IMRT) is the first listed.

NCT02923570 reports 9 study locations spanning 4 distinct geographic areas - top geographies include New York, New Jersey, Florida.

Frequently Asked Questions

What is clinical trial NCT02923570 about?

NCT02923570 is a clinical study titled "Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer". Compared to IMRT, PBRT is thought to give less radiation exposure to the surrounding healthy tissues. It is possible that side effect rates with PBRT will be lower or the same compared to IMRT, but this has not been well studied to date. Although both of these radiation therapies have been used in t...

What is the current status of trial NCT02923570?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2016-10-03. Estimated completion is 2026-10.

What conditions does trial NCT02923570 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT02923570?

The interventions under investigation include: Photon intensity modulated radiation therapy (IMRT) (RADIATION), Proton beam radiotherapy (PBRT) (RADIATION).

Who is sponsoring clinical trial NCT02923570?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02923570 being conducted?

This trial has 9 study locations across Florida, Minnesota, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.